Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Amortizatization of Intangibles: 2023-2025

Historic Amortizatization of Intangibles for Krystal Biotech (KRYS) over the last 3 years, with Sep 2025 value amounting to $209,000.

  • Krystal Biotech's Amortizatization of Intangibles rose 11.17% to $209,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $818,000, marking a year-over-year increase of 3.68%. This contributed to the annual value of $747,000 for FY2024, which is 17.37% down from last year.
  • Latest data reveals that Krystal Biotech reported Amortizatization of Intangibles of $209,000 as of Q3 2025, which was up 7.73% from $194,000 recorded in Q2 2025.
  • Krystal Biotech's 5-year Amortizatization of Intangibles high stood at $233,000 for Q4 2023, and its period low was $182,000 during Q1 2024.
  • Its 3-year average for Amortizatization of Intangibles is $207,091, with a median of $209,000 in 2025.
  • As far as peak fluctuations go, Krystal Biotech's Amortizatization of Intangibles dropped by 18.26% in 2024, and later grew by 23.08% in 2025.
  • Krystal Biotech's Amortizatization of Intangibles (Quarterly) stood at $233,000 in 2023, then dropped by 18.03% to $191,000 in 2024, then grew by 11.17% to $209,000 in 2025.
  • Its last three reported values are $209,000 in Q3 2025, $194,000 for Q2 2025, and $224,000 during Q1 2025.